Sodium-Glucose Cotransporter-2 Inhibitor Use is Associated with a Reduced Risk of Heart Failure Hospitalization in Patients with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes Mellitus : A Real-World Study on a Diverse Urban Population

enthalten in: Drugs - real world outcomes | 2022

von Li, W. | Katamreddy, A. | Kataria, R. | +2

Sodium-Glucose Cotransporter-2 Inhibitor Use is Associated with a Reduced Risk of Heart Failure Hospitalization in Patients with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes Mellitus: A Real-World Study on a Diverse Urban Population

enthalten in: Drugs - real world outcomes | 2021

von Li, W. | Katamreddy, A. | Kataria, R. | +2

Sodium-Glucose Cotransporter-2 Inhibitor Use is Associated with a Reduced Risk of Heart Failure Hospitalization in Patients with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes Mellitus: A Real-World Study on a Diverse Urban Population

enthalten in: Drugs - real world outcomes | 2021

von Li, W. | Katamreddy, A. | Kataria, R. | +2

Sodium-Glucose Cotransporter-2 Inhibitor Use is Associated with a Reduced Risk of Heart Failure Hospitalization in Patients with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes Mellitus: A Real-World Study on a Diverse Urban Population

enthalten in: Drugs - real world outcomes | 2021

von Li, W. | Katamreddy, A. | Kataria, R. | +2